Clinical Trials Directory

Trials / Sponsors / Laekna Limited

Laekna Limited

Industry · 10 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE10
Overweight and Obesity
Phase 12025-12-30
CompletedA Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
Postmenopausal, Healthy Adult Female Participants
Phase 12025-04-22
RecruitingEvaluate LAE102 in Healthy and Overweight/Obese Subjects
Overweight and Obese Volunteers
Phase 12024-06-25
CompletedHuman Mass Balance and Biotransformation Study of [14C]Afuresertib
Healthy Volunteer
Phase 12022-08-06
CompletedAfuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1
Solid Tumor, NSCLC, Cervical Cancer
Phase 1 / Phase 22022-07-01
Active Not RecruitingStudy to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metas
Breast Cancer
Phase 32022-02-18
CompletedPhI to Solid Tumors and PhII to Locally Advanced or mTNBC
Solid Tumor, TNBC - Triple-Negative Breast Cancer
Phase 12021-06-12
CompletedStudy With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Platinum-resistant Ovarian Cancer
Phase 22020-06-09
CompletedDose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Metastatic Castration-resistant Prostate Cancer
Phase 1 / Phase 22019-09-13
TerminatedA Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer
Prostate Cancer Metastatic
Phase 1 / Phase 22019-04-05